InMode Ltd.

INMD Healthcare Medical Devices

InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.

14.16 0.16 −1.12%
Market cap
$824.0M
P/E
11.3×
Fwd P/E
11.8×
Dividend yield
—
F-score
4/9
Altman Z
10.45
Beneish M
−2.25
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Piotroski F-Score
4 4 4 4 7 5 7 — —
P/E ratio
10.06 7.05 9.34 17.99 35.11 23.27 18.95 10.66 10.66
Altman Z-Score
10.45 13.23 18.21 23.49 58.90 28.84 21.03 — —
P/S ratio
2.56 3.35 3.77 6.40 16.08 8.31 7.33 2.96 2.96
P/FCF ratio
11.26 10.03 10.54 16.16 33.05 21.74 18.63 9.81 9.81
Altman Z″-Score (non-manufacturers)
18.86 19.00 20.97 16.63 17.32 15.82 13.56 8.47 7.38
Beneish M-Score
(2.25) (0.67) (1.93) (2.28) (1.58) (2.22) (2.25) (2.87) —
P/Operating CF
41.87 40.82 30.29 50.89 108.68 41.17 41.79 19.79 19.79
P/B ratio
1.39 1.88 2.36 5.24 13.82 6.70 6.37 6.62 6.62
Price to Tangible BV
1.39 1.88 2.36 5.24 13.82 6.70 6.37 6.62 6.62
EV/Sales
1.06 1.84 2.27 5.20 14.91 7.04 6.09 2.29 2.29
EV/EBITDA
4.58 6.43 5.68 11.89 31.74 19.81 15.90 7.96 7.96
EV/Operating CF
4.62 5.49 6.30 13.00 30.49 18.32 15.31 7.47 7.47
EV/FCF
4.68 5.51 6.33 13.12 30.66 18.43 15.48 7.59 7.59
Quick Ratio
8.83 9.38 12.48 7.19 8.66 7.84 6.27 2.41 2.39
Current Ratio
9.88 10.23 13.18 7.67 9.07 8.27 6.56 2.64 2.76
Net Debt/EBITDA
(6.45) (5.27) (3.78) (2.76) (2.48) (3.56) (3.23) (2.59) (2.74)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.48 0.48 0.65 0.81 0.92 0.80 1.04 1.66 0.89
Operating CF/Net income
0.91 0.73 0.89 1.12 1.06 1.06 1.02 1.65 1.66
Capex/Depreciation
(1.40) (0.92) (1.13) (2.32) (1.82) (1.11) (2.29) (2.07) (0.93)
ROE
13.53% 24.31% 29.50% 33.29% 49.15% 34.47% 54.48% 69.77% 28.12%
ROA
12.09% 21.99% 26.25% 28.77% 42.61% 29.19% 40.84% 37.13% 14.64%
ROIC
41.74% 65.52% 267.20% 1,709.17% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
14.88% 28.02% 25.26% 29.39% 39.31% 29.36% 33.66% 45.77% 36.68%
Average Days of Receivables
68.21 54.02 43.49 33.82 33.86 24.92 24.37 34.63 48.30
Research and Development Expense of Revenue
3.59% 3.33% 2.73% 2.74% 2.67% 4.59% 3.64% 4.17% 4.82%
Selling, General and Administrative Expense of Revenue
51.89% 48.48% 41.11% 37.53% 35.73% 45.10% 45.28% 49.36% 61.50%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
3.00% 4.20% 4.80% 5.38% 3.35% 6.23% 1.00% 1.94% 4.56%
Graham Net Nets
0.65 0.48 0.41 0.19 0.07 0.15 0.15 0.18 0.18
Graham Number
18.63 21.75 22.47 17.22 15.20 9.02 8.46 2.82 0.00
Earnings Yield
9.94% 14.19% 10.71% 5.56% 2.85% 4.30% 5.28% 9.38% 9.38%
Free Cash Flow Yield
8.88% 9.97% 9.49% 6.19% 3.03% 4.60% 5.37% 10.19% 10.19%
Revenue per Share
5.73 4.98 5.89 5.51 4.39 2.86 2.67 1.88 1.02
Operating CF per Share
1.32 1.67 2.12 2.20 2.15 1.10 1.06 0.69 0.28
Capex per Share
(0.01) (0.01) (0.01) (0.02) (0.01) (0.01) (0.01) (0.01) 0.00
Free Cash Flow per Share
1.30 1.66 2.11 2.18 2.14 1.09 1.05 0.69 0.27
Cash per Share
8.59 7.52 8.88 6.64 5.11 3.61 3.31 1.15 0.48
Shareholders Equity per Share
10.57 8.87 9.43 6.72 5.11 3.54 3.08 0.84 0.37
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
10.57 8.87 9.43 6.72 5.11 3.54 3.08 0.84 0.37
Free Cash Flow
84.29 132.00 176.12 180.00 173.95 78.76 61.51 36.51 14.42
Working Capital
627.88 644.60 781.19 547.35 418.26 254.56 180.71 48.34 23.69
Capital Expenditures
(0.97) (0.67) (0.70) (1.57) (0.94) (0.46) (0.69) (0.38) (0.19)
Net Current Asset Value
615.39 632.60 769.42 539.58 407.38 249.31 174.63 41.38 17.16
EV/EBIT
4.62 6.47 5.70 11.93 31.84 19.93 15.98 8.01 8.01
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
11.12 11.77 9.49 14.70 34.32 23.50 19.22 10.35 10.35
Other line items
Depreciation/Fixed assets
0.27 0.31 0.26 0.30 0.37 0.42 0.32 0.34 0.59
Cash ROIC
6.81% 10.15% 11.52% 16.33% 20.91% 15.26% 16.48% 34.45% 32.41%
Accounts Receivable Turnover
5.80 6.75 9.77 12.07 15.14 16.82 15.68 12.08 6.45
Accounts Payable Turnover
5.02 5.60 5.34 5.87 7.06 6.10 4.93 3.98 2.39
Inventory Turnover
1.19 1.49 1.90 2.41 2.98 2.53 2.47 2.51 1.51
Average Days of Payables
82.21 64.70 63.16 80.67 59.79 75.84 66.77 109.30 123.53
Days of Inventory on Hand
339.87 279.54 203.94 198.17 143.20 177.28 169.68 168.79 203.00
Average Receivables
63.83 58.53 50.36 37.63 23.62 12.26 9.97 8.29 8.29
Average Payables
15.85 13.87 15.10 12.51 7.59 5.06 4.11 3.79 3.79
Average Inventory
66.80 52.32 42.50 30.46 18.00 12.20 8.19 6.00 6.00
Average Assets
776.05 824.48 753.85 561.48 387.15 257.07 149.72 60.25 60.25
Average Common Equity
693.51 745.59 671.00 485.21 335.64 217.64 112.24 32.06 31.36

Fold the line items

Columns are period end dates